Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
China flag China · Delayed Price · Currency is CNY
50.81
+0.20 (0.40%)
May 8, 2026, 3:00 PM CST

SHA:688050 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9,82711,73217,25418,10724,26422,103
Market Cap Growth
-49.01%-32.01%-4.71%-25.37%9.78%21.53%
Enterprise Value
10,59411,88217,62517,74724,23221,769
Last Close Price
50.8160.6690.5794.78126.81115.35
PE Ratio
36.9943.7544.4259.57104.27129.00
Forward PE
22.6026.5629.8546.1681.03105.28
PS Ratio
6.457.9112.2419.0441.8751.04
PB Ratio
3.143.956.557.6912.6412.70
P/TBV Ratio
4.984.888.309.9314.0114.16
P/FCF Ratio
45.8447.69944.35---
P/OCF Ratio
31.4631.7849.6285.1697.01100.79
PEG Ratio
-1.311.311.311.942.52
EV/Sales Ratio
6.958.0112.5018.6641.8250.27
EV/EBITDA Ratio
18.0821.0731.1646.6489.28115.75
EV/EBIT Ratio
26.0529.4940.2957.59104.62137.88
EV/FCF Ratio
49.4148.30964.66---
Debt / Equity Ratio
0.390.200.230.180.090.09
Debt / EBITDA Ratio
2.101.011.071.090.590.82
Debt / FCF Ratio
5.752.3633.33---
Net Debt / Equity Ratio
0.16-0.070.04-0.06-0.35-0.46
Net Debt / EBITDA Ratio
0.88-0.380.20-0.36-2.48-4.25
Net Debt / FCF Ratio
2.35-0.886.170.8732.258.69
Asset Turnover
0.370.400.430.360.270.24
Inventory Turnover
1.651.852.111.771.311.18
Quick Ratio
2.293.012.862.056.397.37
Current Ratio
3.113.943.952.717.198.02
Return on Equity (ROE)
8.17%8.59%15.51%13.38%12.42%10.21%
Return on Assets (ROA)
6.13%6.82%8.34%7.26%6.75%5.35%
Return on Invested Capital (ROIC)
10.51%12.19%15.82%15.53%18.22%17.03%
Return on Capital Employed (ROCE)
9.80%11.60%13.70%11.50%11.00%8.30%
Earnings Yield
2.70%2.29%2.25%1.68%0.96%0.78%
FCF Yield
2.18%2.10%0.11%-0.87%-0.09%-0.42%
Dividend Yield
0.69%-0.39%0.29%0.22%0.18%
Payout Ratio
33.50%33.36%18.17%20.19%19.10%17.81%
Buyback Yield / Dilution
-2.01%-1.10%0.27%-0.25%-0.17%-17.57%
Total Shareholder Return
-1.32%-1.10%0.66%0.04%0.06%-17.39%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.